US4276885A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Ultrasonic image enhancement
Assignee: Bayer Pharma AG
•
Filing: 1979-05-04
•
Granted: 1981-07-07
•
Expires: 1999-05-04
Abstract
Abstract Ultrasonic images of flowing streams can provide important information regarding the streams. Herein, a plurality of microbubbles are provided in such streams to enhance such images, aid in tumor detection and treatment, provide mapping of vascularity of tissue masses and measure instantaneous blood flow rate. The preferred microbubbles have a coalescence resistant surface membrane encapsulating a gas of a selected composition, the membrane including non-toxic and non-antigenic organic molecules. Preferrably, the microbubbles have diameters in the 0.5 micron-300 micron range.
Inventors
- 👤 Ernest G. Tickner
- 👤 Ned S. Rasor
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 04:25
CPC Classifications
A; A61; A61B; A61B8/00; A61B8/48; A61B8/481; A61K; A61K49/00; A61K49/22; A61K49/222; A61K49/223; G; G01; G01N; G01N29/00; G01N29/04; G01N29/06; A61B17/00; A61B17/22; A61B2017/22082; A61B2017/22089; G01N2291/00; G01N2291/02; G01N2291/028; G01N2291/02872
Claims Analysis
Total Claims: 20
Claim 1
Independent Claim
102 words
A method of enhancing ultrasonic echographic imaging in a liquid enclosed in a vessel by increasing image contrast, comprising: providing a plurality of microbubbles in said liquid, each of said microbubbles having a coalescence resistant surface membrane encapsulating a gas of a selected composition, said membrane including a multiplicity of non-toxic and non-antigenic organic molecules, said microbubbles having a diameter of no more than about 300 microns and no less than about 0.5 micron; and obtaining an enhanced ultrasonic echographic image of said liquid opposite a position therein containing said microbubbles by increasing the relative contrast between said liquid and said vessel.
Claim 2
Independent Claim
102 words
A method of enhancing ultrasonic echographic imaging in a liquid enclosed in a vessel by increasing image contrast, comprising: providing a plurality of microbubbles in said liquid, each of said microbubbles having a coalescence resistant surface membrane encapsulating a gas of a selected composition, said membrane including a multiplicity of non-toxic and non-antigenic organic molecules, said microbubbles having a diameter of no more than about 300 microns and no less than about 0.5 micron; and obtaining an enhanced ultrasonic echographic image of said liquid opposite a position therein containing said microbubbles by increasing the relative contrast between said liquid and said vessel.
Claim 3
Dependent Claim
17 words
A method as in claim 1, wherein said liquid is a blood stream of a test subject.
Claim 4
Dependent Claim
36 words
A method as in claim 1, wherein said molecules each have a hydrophilic portion and a hydrophobic portion and said hydrophilic portions of said molecules are aligned radially away from a center of a respective microbubble.
Claim 5
Dependent Claim
14 words
A method as in claim 1, wherein said membrane is of a gellable composition.
Claim 6
Dependent Claim
12 words
A method as in claim 4, wherein said gellable composition is gelatin.
Claim 7
Independent Claim
69 words
A method of detecting tumors in a living subject, comprising: providing a substance in a blood stream of said test subject, said substance providing a plurality of microbubbles in said blood stream, substantially all of said microbubbles being of generally a uniform size; obtaining an enhanced ultrasonic echographic image of said bubbles at a possible tumor; and examining said image for evidence of neovascularization indicative of said possible tumor.
Claim 8
Independent Claim
69 words
A method of detecting tumors in a living subject, comprising: providing a substance in a blood stream of said test subject, said substance providing a plurality of microbubbles in said blood stream, substantially all of said microbubbles being of generally a uniform size; obtaining an enhanced ultrasonic echographic image of said bubbles at a possible tumor; and examining said image for evidence of neovascularization indicative of said possible tumor.
Claim 9
Independent Claim
82 words
A method of detecting tumors in a living subject, comprising: providing a substance, comprising a plurality of microbubbles each having a surface membrane encapsulating a gas of a selected composition, said membrane including a multiplicity of non-toxic and non-antigenic organic molecules, in a blood stream of said test subject, said substance providing a plurality of microbubbles in said blood stream; obtaining an enhanced ultrasonic echographic image of said bubbles; and examining said image for evidence of neovascularization indicative of a possible tumor.
Claim 10
Independent Claim
82 words
A method of detecting tumors in a living subject, comprising: providing a substance, comprising a plurality of microbubbles each having a surface membrane encapsulating a gas of a selected composition, said membrane including a multiplicity of non-toxic and non-antigenic organic molecules, in a blood stream of said test subject, said substance providing a plurality of microbubbles in said blood stream; obtaining an enhanced ultrasonic echographic image of said bubbles; and examining said image for evidence of neovascularization indicative of a possible tumor.
Claim 11
Dependent Claim
61 words
A method as in claim 7, wherein said molecules each have a hydrophilic portion and a hydrophobic portion, said hydrophilic portions of said molecules being aligned radially away from a center of each respective bubble, said microbubbles are of generally a uniform size and of a diameter of no more than about 300 microns and no less than about 0.5 micron.
Claim 12
Dependent Claim
14 words
A method as in claim 7, wherein said membrane is of a gellable composition.
Claim 13
Dependent Claim
11 words
A method as in claim 7, wherein said membrane comprises gelatin.
Claim 14
Independent Claim
176 words
A method of mapping the vascularity of a tissue mass, comprising: injecting a plurality of microbubbles, substantially all of which fall in a selected narrow size range, into a blood stream of a test subject, each of said microbubbles having a coalescing resistant surface membrane encapsulating a gas of a selected composition, said membrane including a multiplicity of non-toxic and non-antigenic organic molecules, said molecules having a diameter of between about 0.5 micron and 300 microns; obtaining an enhanced ultrasonic echographic image of the tissue mass soon after the microbubbles have flowed thereto and lodged at a first bifurcation of a first vascular size corresponding to that of the injected microbubble size range; and obtaining an additional enhanced ultrasonic echographic image of the tissue mass after a selected period of time during which the microbubbles have generally uniformly shrunk, due to dissolution thereof, to a known reduced size, have flowed past said first bifurcation, and have lodged at a second bifurcation of a second vascular size corresponding to that of the reduced size microbubble size range.
Claim 15
Independent Claim
176 words
A method of mapping the vascularity of a tissue mass, comprising: injecting a plurality of microbubbles, substantially all of which fall in a selected narrow size range, into a blood stream of a test subject, each of said microbubbles having a coalescing resistant surface membrane encapsulating a gas of a selected composition, said membrane including a multiplicity of non-toxic and non-antigenic organic molecules, said molecules having a diameter of between about 0.5 micron and 300 microns; obtaining an enhanced ultrasonic echographic image of the tissue mass soon after the microbubbles have flowed thereto and lodged at a first bifurcation of a first vascular size corresponding to that of the injected microbubble size range; and obtaining an additional enhanced ultrasonic echographic image of the tissue mass after a selected period of time during which the microbubbles have generally uniformly shrunk, due to dissolution thereof, to a known reduced size, have flowed past said first bifurcation, and have lodged at a second bifurcation of a second vascular size corresponding to that of the reduced size microbubble size range.
Claim 16
Dependent Claim
36 words
A method as in claim 11, wherein said organic molecules each have a hydrophilic portion and a hydrophobic portion, said hydrophilic portions of said molecules being aligned radially away from a center of each respective microbubble.
Claim 17
Dependent Claim
14 words
A method as in claim 11, wherein said membrane is of a gellable composition.
Claim 18
Dependent Claim
12 words
A method as in claim 13, wherein said gellable composition is gelatin.
Claim 19
Independent Claim
82 words
A method of detecting tumorous tissue in a living subject, comprising: providing a substance in an afferent vasculature of said test subject upstream of a possible tumor, said substance providing a plurality of microbubbles in said blood stream substantially all of a diameter too large to pass through normal capillaries but small enough to pass through tumorous capillaries; and obtaining an enhanced ultrasonic echographic image of a corresponding efferent vasculature downstream of said possible tumor and noting if such microbubbles are present.
Claim 20
Independent Claim
82 words
A method of detecting tumorous tissue in a living subject, comprising: providing a substance in an afferent vasculature of said test subject upstream of a possible tumor, said substance providing a plurality of microbubbles in said blood stream substantially all of a diameter too large to pass through normal capillaries but small enough to pass through tumorous capillaries; and obtaining an enhanced ultrasonic echographic image of a corresponding efferent vasculature downstream of said possible tumor and noting if such microbubbles are present.
References Cited (Backward Citations)
US3640271A
Cited
US4182173A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1984-07-06 | 1985-01-05 | 1985-07-07 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1988-07-06 | 1989-01-05 | 1989-07-07 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1992-07-06 | 1993-01-05 | 1993-07-07 | $7700.00 | Window Closed / Lapsed |